Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Argentine hospitals cut unnecessary lab tests with new program

NCT ID NCT07629219

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program to reduce unnecessary lab tests in hospitalized patients in Argentina. The program included redesigning how tests are ordered, reusing samples, educating doctors, and giving feedback on test use. Researchers studied 600 patients in internal medicine and intensive care units to see if the program lowered test use without harming patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multicomponent Diagnostic Stewardship Bundle (behavioral intervention)
What this could lead to
If successful, this could provide a proven way for hospitals in Latin America to reduce unnecessary lab tests, saving money and improving patient care.
What could go wrong
This is a completed implementation study, not a treatment trial. The results may not apply to other regions or hospital types, and the intervention may not be sustainable long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

600 people

The number who actually took part.

Started

Jun 2025

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients (≥18 years) hospitalized in participating internal medicine wards or intensive care units during the study period. Exclusion Criteria: * None at the individual level. The intervention is implemented at the unit level and applies to all admitted adult patients during the study period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clinical laboratory techniques are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Alemán

    Buenos Aires, Buenos Aires F.D., C1425ASQ, Argentina

  • Hospital Austral

    Pilar, Buenos Aires, B1629WTA, Argentina

  • Hospital General de Agudos Dalmacio Vélez Sarsfield

    Buenos Aires, Buenos Aires F.D., 1407, Argentina

  • Hospital Interzonal General de Agudos Dr. Diego Paroissien

    Isidro Casanova, Buenos Aires, B1765, Argentina

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Buenos Aires F.D., C1199ABB, Argentina

  • Hospital Italiano de San Justo

    San Justo, Buenos Aires, 1754, Argentina

  • Hospital Municipal de Agudos Dr. Leónidas Lucero

    Bahía Blanca, Buenos Aires, B8000, Argentina

  • Hospital Privado Universitario de Córdoba

    Córdoba, Córdoba Province, X5016KEH, Argentina

More trials for these conditions

Other studies related to the condition(s) this trial covers.